0001628280-23-002987.txt : 20230209 0001628280-23-002987.hdr.sgml : 20230209 20230209165059 ACCESSION NUMBER: 0001628280-23-002987 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230130 FILED AS OF DATE: 20230209 DATE AS OF CHANGE: 20230209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kabbinavar Fairooz CENTRAL INDEX KEY: 0001774182 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35558 FILM NUMBER: 23607022 MAIL ADDRESS: STREET 1: C/O TOCAGEN INC. STREET 2: 4242 CAMPUS POINT COURT, STE. 500 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiff Oncology, Inc. CENTRAL INDEX KEY: 0001213037 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 272004382 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-952-7570 MAIL ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Trovagene, Inc. DATE OF NAME CHANGE: 20130304 FORMER COMPANY: FORMER CONFORMED NAME: TrovaGene Inc. DATE OF NAME CHANGE: 20110830 FORMER COMPANY: FORMER CONFORMED NAME: XENOMICS INC DATE OF NAME CHANGE: 20040719 3 1 wf-form3_167597942775635.xml FORM 3 X0206 3 2023-01-30 0 0001213037 Cardiff Oncology, Inc. CRDF 0001774182 Kabbinavar Fairooz C/O CARDIFF ONCOLOGY, INC. 11055 FLINTKOTE AVE SAN DIEGO CA 92121 0 1 0 0 Chief Medical Officer Stock Options 1.75 2033-01-30 Common Stock 425000.0 D 25% of the shares subject to the option will vest on January 30, 2024 and the remaining shares vest in 36 equal monthly installments thereafter, subject to Dr. Kabbinavar's continued service. /s/ Fairooz Kabbinavar 2023-02-09